1. Home
  2. TXG vs PATH Comparison

TXG vs PATH Comparison

Compare TXG & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$48.21

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Logo UiPath Inc.

PATH

UiPath Inc.

HOLD

Current Price

$12.75

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
PATH
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Computer Software: Prepackaged Software
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.6B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
TXG
PATH
Price
$48.21
$12.75
Analyst Decision
Hold
Hold
Analyst Count
15
17
Target Price
$20.25
$14.41
AVG Volume (30 Days)
2.8M
82.2M
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
500.00
EPS
N/A
0.04
Revenue
$245,893,000.00
$1,610,572,000.00
Revenue This Year
N/A
$11.82
Revenue Next Year
$7.33
$8.50
P/E Ratio
N/A
$308.88
Revenue Growth
68.06
12.65
52 Week Low
$11.17
$9.20
52 Week High
$49.84
$19.84

Technical Indicators

Market Signals
Indicator
TXG
PATH
Relative Strength Index (RSI) 61.65 61.13
Support Level $16.11 $12.36
Resistance Level N/A $12.83
Average True Range (ATR) 2.89 0.78
MACD -0.23 0.08
Stochastic Oscillator 60.79 89.70

Price Performance

Historical Comparison
TXG
PATH

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.

Share on Social Networks: